{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:06Z","timestamp":1791916626823,"version":"4.3.4"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtos.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:27:44Z","timestamp":1732663664000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Ocular surface squamous neoplasia: Update on genetics, epigenetics and opportunities for targeted therapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Nefeli Eleni","family":"Kounatidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Vitkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Palioura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2024.11.006_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","article-title":"Tumors of the conjunctiva and cornea","volume":"49","author":"Shields","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1442-9071.1997.tb01514.x","article-title":"Retrospective study of ocular surface squamous neoplasia","volume":"25","author":"Lee","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/bjo.83.1.98","article-title":"Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases","volume":"83","author":"Tunc","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/bjo.86.2.168","article-title":"Squamous cell carcinoma of the conjunctiva: a series of 26 cases","volume":"86","author":"McKelvie","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40123-020-00294-2","article-title":"Intraocular invasion of ocular surface squamous neoplasia through a corneal wound","volume":"9","author":"Laura","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2024.11.006_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exer.2014.10.015","article-title":"Pathophysiology of ocular surface squamous neoplasia","volume":"129","author":"Gichuhi","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.ophtha.2009.09.031","article-title":"Demographics, etiology, and behavior of conjunctival squamous cell carcinoma in the 21st century","volume":"116","author":"Karcioglu","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.11.006_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/bjc.2013.539","article-title":"HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis","volume":"109","author":"Carreira","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5858\/133.8.1246","article-title":"Lack of association of high-risk human papillomavirus in ocular surface squamous neoplasia in India","volume":"133","author":"Manderwad","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/02713680903007162","article-title":"No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany","volume":"34","author":"Guthoff","year":"2009","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib11","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41379-020-0571-7","article-title":"Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes","volume":"33","author":"Lazo de la Vega","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib12","article-title":"Human papilloma virus identification in ocular surface squamous neoplasia by p16 immunohistochemistry and DNA chip test A strobe-compliant article","volume":"98","author":"Shrestha","year":"2019","journal-title":"M\u00e9d"},{"key":"10.1016\/j.jtos.2024.11.006_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0161-6420(97)30287-5","article-title":"Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia","volume":"104","author":"Tabin","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.11.006_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17469899.2017.1263567","article-title":"Diagnosis and medical management of ocular surface squamous neoplasia","volume":"12","author":"Sayed-Ahmed","year":"2017","journal-title":"Expet Rev Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib15","article-title":"The management of ocular surface squamous neoplasia (OSSN)","volume":"24","author":"Yeoh","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41433-023-02434-x","article-title":"Medical treatment for ocular surface squamous neoplasia","volume":"37","author":"Monroy","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2024.11.006_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1442-9071.2009.02092.x","article-title":"Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion","volume":"37","author":"Walsh-Conway","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.11.024","article-title":"Management of invasive squamous cell carcinomas of the conjunctiva","volume":"200","author":"Santoni","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/IOP.0b013e31820d872f","article-title":"Electron beam radiation for conjunctival squamous carcinoma","volume":"27","author":"Graue","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2024.11.006_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2022.01.016","article-title":"Mutational landscape and outcomes of conjunctival melanoma in 101 patients","volume":"129","author":"Lally","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.11.006_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archopht.120.5.554","article-title":"Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia","volume":"120","author":"Mahomed","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/mutage\/geh048","article-title":"TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis","volume":"19","author":"Ateenyi-Agaba","year":"2004","journal-title":"Mutagenesis"},{"key":"10.1016\/j.jtos.2024.11.006_bib23","first-page":"530","article-title":"The evaluation of human papillomavirus and p53 gene mutation in benign and malignant conjunctiva and eyelid lesions","volume":"48","author":"Joanna","year":"2010","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.jtos.2024.11.006_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jtos.2020.07.011","article-title":"Whole exome profiling and mutational analysis of ocular surface squamous neoplasia","volume":"18","author":"Ramos-betancourt","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.11.006_bib25","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1111\/aos.14844","article-title":"Stratifin in ocular surface squamous neoplasia and its association with p53","volume":"99","author":"Chauhan","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00428-005-0104-2","article-title":"Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva: not associated with human papillomavirus infection","volume":"448","author":"Jung","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtos.2024.11.006_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41379-019-0350-5","article-title":"Human papillomavirus type 16 causes a defined subset of conjunctival in situ squamous cell carcinomas","volume":"33","author":"Griffin","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjophthalmol-2017-311276","article-title":"P16INK4a overexpression as a predictor of survival in ocular surface squamous neoplasia","volume":"102","author":"Chauhan","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib29","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/PAI.0000000000000592","article-title":"Loss of pRB in conjunctival squamous cell carcinoma: a predictor of poor prognosis","volume":"26","author":"Chauhan","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jtos.2024.11.006_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502096","article-title":"P16 expression correlates with invasive ocular surface squamous neoplasms in HIV-infected Mozambicans","volume":"6","author":"Carrilho","year":"2020","journal-title":"Ocul Oncol Pathol"},{"issue":"1","key":"10.1016\/j.jtos.2024.11.006_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ophtha.2015.06.049","article-title":"Whole exome profiling of ocular surface squamous neoplasia","volume":"123","author":"Galor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.11.006_bib32","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1167\/iovs.14-14920","article-title":"Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma","volume":"55","author":"Asnaghi","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0238120","article-title":"Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment","volume":"15","author":"Sakai","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.iop.0000202609.92772.c3","article-title":"Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma","volume":"22","author":"Shepler","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2024.11.006_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pone.0010477","article-title":"HPV infection and EGFR activation\/alteration in HIV-infected East African patients with conjunctival carcinoma","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-9378-9-7","article-title":"Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV\/AIDS-related squamous cell carcinoma of conjunctiva","volume":"9","author":"Mwololo","year":"2014","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib37","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1167\/iovs.15-17469","article-title":"Frequent TERT promoter mutations in ocular surface squamous neoplasia","volume":"56","author":"Scholz","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4103\/ijo.IJO_1342_21","article-title":"Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma","volume":"70","author":"Jayaraj","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib39","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1167\/iovs.08-1988","article-title":"Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia","volume":"49","author":"Ng","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jtos.2013.01.006","article-title":"Matrix metalloproteinases and their inhibitors in squamous cell carcinoma of the conjunctiva","volume":"11","author":"Di Girolamo","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.11.006_bib41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.2016.41","article-title":"Altered gene expression in conjunctival squamous cell carcinoma","volume":"29","author":"Mahale","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1213426","article-title":"Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target","volume":"13","author":"Julius","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.oftal.2022.02.005","article-title":"OVOL1 immunohistochemical expression is a useful tool to diagnose invasion in ocular surface squamous neoplasms","volume":"97","author":"Ter\u00e1n","year":"2022","journal-title":"Arch La Soc Espa\u00f1ola Oftalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajo.2018.12.020","article-title":"Programmed cell death 1 ligand 1 and programmed cell death 1 ligand 2 are expressed in conjunctival invasive squamous cell carcinoma: therapeutic implications","volume":"200","author":"Wolkow","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0263895","article-title":"FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment","volume":"17","author":"Tagami","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib46","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.19-26894","article-title":"PD-L1\/PD1 expression, composition of tumor-associated immune infiltrate, and HPV status in conjunctival squamous cell carcinoma","volume":"60","author":"Nagarajan","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4161\/epi.6.3.14182","article-title":"Hypermethylation of multiple tumor-related genes associated with DMNT3b upregulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma","volume":"6","author":"Li","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.jtos.2024.11.006_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijbiomac.2021.11.120","article-title":"Functional impact of titin (TTN) mutations in ocular surface squamous neoplasia","volume":"195","author":"Djulbegovic","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jtos.2024.11.006_bib49","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s00417-021-05236-7","article-title":"Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival","volume":"259","author":"Tagami","year":"2021","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib50","first-page":"2408","article-title":"Deleted in Liver Cancer-1 (DLC-1) is highly expressed in conjunctival squamous neoplasia and acts as an oncogene in high grade lesions","volume":"57","author":"Sardinha","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/aqw007","article-title":"Analysis of HSP90 expression is valuable in the differential diagnosis of ocular surface squamous lesions","volume":"145","author":"Zoroquiain","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib52","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.ophtha.2012.03.037","article-title":"Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome","volume":"119","author":"Lange","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.11.006_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2019.08.020","article-title":"ADAM3A copy number gains occur in a subset of conjunctival squamous cell carcinoma and its high grade precursors","volume":"94","author":"Vizcaino","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161800","article-title":"Differential expression of stem cell markers in ocular surface squamous neoplasia","volume":"11","author":"Mishra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00417-005-0025-4","article-title":"Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma","volume":"244","author":"Auw-Haedrich","year":"2006","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol = Albr von Graefes Arch Fur Klin Und Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jtos.2024.11.006_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.31063","article-title":"Distinct pattern of TP53 mutations in human immunodeficiency virus\u2013related head and neck squamous cell carcinoma","volume":"124","author":"Gleber-Netto","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jtos.2024.11.006_bib59","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1600-0714.2009.00767.x","article-title":"Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders","volume":"38","author":"\u00d6gmundsd\u00f3ttir","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2009.22.4170","article-title":"TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma","volume":"28","author":"Perrone","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0247498","article-title":"Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma","volume":"16","author":"Nannapaneni","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib62","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1073\/pnas.0802091105","article-title":"Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway","volume":"105","author":"Kravchenko","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib63","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/cc.10.10.15642","article-title":"Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs","volume":"10","author":"Puca","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jtos.2024.11.006_bib64","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41467-023-37223-3","article-title":"Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities","volume":"14","author":"Ho","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2024.11.006_bib65","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/onc.2012.148","article-title":"Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion","volume":"32","author":"Muller","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jtos.2024.11.006_bib66","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1097-2765(00)00072-1","article-title":"Requirements for cell cycle arrest by p16INK4a","volume":"6","author":"Bruce","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib67","doi-asserted-by":"crossref","DOI":"10.15761\/CRR.1000145","article-title":"Aberrant expression of p16(INK4a) in human cancers - a new biomarker?","volume":"2","author":"Inoue","year":"2018","journal-title":"Cancer Reports Rev"},{"key":"10.1016\/j.jtos.2024.11.006_bib68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0595-114","article-title":"Mutations associated with familial melanoma impair p16INK4 function","volume":"10","author":"Ranade","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtos.2024.11.006_bib69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42003-020-0873-9","article-title":"Pan-cancer molecular analysis of the RB tumor suppressor pathway","volume":"3","author":"Knudsen","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.jtos.2024.11.006_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mc.20456","article-title":"Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines","volume":"48","author":"Bourgo","year":"2009","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jtos.2024.11.006_bib71","article-title":"p16 immunohistochemical expression in head and neck squamous cell carcinoma: association with prognostic parameters","volume":"12","author":"Hashmi","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jtos.2024.11.006_bib72","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/modpathol.3800324","article-title":"Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma","volume":"18","author":"Roesch","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PAS.0000000000000581","article-title":"Evaluation for high-risk HPV in squamous cell carcinomas and precursor lesions arising in the conjunctiva and lacrimal sac","volume":"40","author":"Afrogheh","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.01.002","article-title":"Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis","volume":"54","author":"Sedghizadeh","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10555-020-09940-4","article-title":"Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology?","volume":"40","author":"Riess","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jtos.2024.11.006_bib76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/327239a0","article-title":"Scatter factor is a fibroblast-derived modulator of epithelial cell mobility","volume":"327","author":"Stoker","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jtos.2024.11.006_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-018-0109-8","article-title":"Inhibition of HGF\/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer","volume":"8","author":"Bonan","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jtos.2024.11.006_bib78","first-page":"4005","article-title":"HGF\/Met signaling in head and neck cancer: impact on the tumor microenvironment. Clin cancer res an off","volume":"22","author":"Hartmann","year":"2016","journal-title":"J Am Assoc Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib79","unstructured":"UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res n.d.;51:D523\u2013D531."},{"key":"10.1016\/j.jtos.2024.11.006_bib80","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtos.2024.11.006_bib81","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s13277-013-1308-8","article-title":"Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma","volume":"35","author":"Karabulut","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jtos.2024.11.006_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/biomedicines3010149","article-title":"Recent progress and advances in HGF\/MET-targeted therapeutic agents for cancer treatment","volume":"3","author":"Zhang","year":"2015","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtos.2024.11.006_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-10995-z","article-title":"Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.17","article-title":"Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy","volume":"49","author":"Kim","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2009","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib86","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2024.11.006_bib87","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-014-0071-z","article-title":"High-resolution genome-wide analysis identified recurrent genetic alterations in NK\/T-cell lymphoma, nasal type, which are associated with disease progression","volume":"31","author":"Sun","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/genes13122408","article-title":"Association of inherited copy number variation in ADAM3A and ADAM5 pseudogenes with oropharynx cancer risk and outcome","volume":"13","author":"Carron","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.jtos.2024.11.006_bib89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13039-020-00491-5","article-title":"Identifying novel genetic alterations in pediatric acute lymphoblastic leukemia based on copy number analysis","volume":"13","author":"Batista-Gomes","year":"2020","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.jtos.2024.11.006_bib90","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41388-022-02583-5","article-title":"The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review","volume":"42","author":"Arai","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jtos.2024.11.006_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.jtos.2024.11.006_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jtos.2024.11.006_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-1-11","article-title":"The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications","volume":"1","author":"Zimmermann","year":"2006","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib94","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/1097-0215(20001120)89:6<484::AID-IJC3>3.0.CO;2-S","article-title":"Co-expression of epidermal growth factor receptor and transforming growth factor-\u03b1 predicts worse prognosis in breast-cancer patients","volume":"89","author":"Umekita","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib95","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-\u03b1 and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtos.2024.11.006_bib96","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/sj.bjc.6602149","article-title":"Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer","volume":"91","author":"Swinson","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-018-0413-9","article-title":"Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer","volume":"18","author":"Mansour","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.jtos.2024.11.006_bib98","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.21802","article-title":"EGFR expression in advanced head and neck cutaneous squamous cell carcinoma","volume":"34","author":"Sweeny","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.jtos.2024.11.006_bib99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.47162\/RJME.62.1.19","article-title":"The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma","volume":"62","author":"Nichita","year":"2021","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jtos.2024.11.006_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/901320","article-title":"EGFR monoclonal antibodies in the treatment of squamous cell carcinoma of the head and neck: a view beyond cetuximab","volume":"2012","author":"Kono","year":"2012","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.jtos.2024.11.006_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920949418","article-title":"Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy","volume":"13","author":"Fasano","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gene.2012.01.095","article-title":"Regulation of the human catalytic subunit of telomerase (hTERT)","volume":"498","author":"Daniel","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.jtos.2024.11.006_bib103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jclinpath-2018-205653","article-title":"TERT gene: its function and dysregulation in cancer","volume":"72","author":"Colebatch","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib104","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jtos.2024.11.006_bib105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jtos.2024.11.006_bib106","first-page":"1546","volume":"vol. 10","author":"Nagore","year":"2019"},{"key":"10.1016\/j.jtos.2024.11.006_bib107","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/0008-5472.CAN-19-2560","article-title":"Epigenetic targeting of TERT-associated gene expression signature in human neuroblastoma with TERT overexpression","volume":"80","author":"Huang","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib108","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1503479","article-title":"Telomerase inhibitor imetelstat in patients with essential thrombocythemia","volume":"373","author":"Baerlocher","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.jtos.2024.11.006_bib111","first-page":"499","article-title":"Matrix metalloproteinase-1 production observed after solar-simulated radiation exposure is assumed by dermal fibroblasts but involves a paracrine activation through epidermal keratinocytes","volume":"79","author":"Fagot","year":"2004","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jtos.2024.11.006_bib112","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","article-title":"Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation","volume":"180","author":"Jeong","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib113","first-page":"1","article-title":"Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib114","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2559.2007.02885.x","article-title":"Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression","volume":"51","author":"O'Grady","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.jtos.2024.11.006_bib115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.7314\/APJCP.2015.16.4.1327","article-title":"Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma","volume":"16","author":"Lotfi","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.jtos.2024.11.006_bib116","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1515\/cclm-2012-0504","article-title":"Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer","volume":"51","author":"Chang","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib117","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919864247","article-title":"TIMP-3 as a therapeutic target for cancer","volume":"11","author":"Su","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib118","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0714.2007.00546.x","article-title":"Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis","volume":"36","author":"De Vicente","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib119","first-page":"509","article-title":"Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC)","volume":"18","author":"Jiao","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib120","first-page":"1","article-title":"Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma","volume":"21","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib121","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.oraloncology.2012.10.005","article-title":"Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy","volume":"49","author":"Vir\u00f3s","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib122","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-08-3255","article-title":"Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis","volume":"69","author":"Devy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700867","article-title":"Drug-Bearing supramolecular MMP inhibitor nanofibers for inhibition of metastasis and growth of liver cancer","volume":"5","author":"Ji","year":"2018","journal-title":"Adv Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib124","doi-asserted-by":"crossref","first-page":"15431","DOI":"10.1073\/pnas.1204600109","article-title":"Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C 82(OH)22 and its implication for de novo design of nanomedicine","volume":"109","author":"Kang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib125","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2217\/nnm-2019-0298","article-title":"Hampering brain tumor proliferation and migration using peptide nanofiber:siPLK1\/MMP2 complexes","volume":"14","author":"Mazza","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jtos.2024.11.006_bib126","first-page":"1","article-title":"PLAU1 facilitated proliferation, invasion, and metastasis via interaction with MMP1 in head and neck squamous carcinoma","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib127","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1172\/JCI96519","article-title":"ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation","volume":"128","author":"Vendetti","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtos.2024.11.006_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060925","article-title":"Kinase inhibitors of dna-pk, atm and atr in combination with ionizing radiation can increase tumor cell death in hnscc cells while sparing normal tissue cells","volume":"12","author":"Faulhaber","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jtos.2024.11.006_bib129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/cgt.2010.7","article-title":"Antisense HIF-1\u03b1 prevents acquired tumor resistance to angiostatin gene therapy","volume":"17","author":"Sun","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jtos.2024.11.006_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12082296","article-title":"Transcription factors in cancer development and therapy","volume":"12","author":"Vishnoi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jtos.2024.11.006_bib132","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00417-020-04734-4","article-title":"HIF-1\u03b1, HIF-2\u03b1, and ProExC: diagnostic or prognostic relevance in conjunctival intraepithelial neoplasia?","volume":"258","author":"Nuessle","year":"2020","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib133","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1167\/iovs.18-26423","article-title":"KLF4 regulates corneal epithelial cell cycle progression by suppressing canonical TGF-b signaling and upregulating cdk inhibitors P16 and P27","volume":"60","author":"Tiwari","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib134","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1600-0463.2007.apm_643.x","article-title":"Genetic and epigenetic analysis of the KLF4 gene in gastric cancer","volume":"115","author":"Cho","year":"2007","journal-title":"Apmis"},{"key":"10.1016\/j.jtos.2024.11.006_bib135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib136","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","article-title":"Hippo pathway-independent restriction of TAZ and YAP by angiomotin","volume":"286","author":"Chan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2024.11.006_bib137","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/abbs\/gmu110","article-title":"The regulation and function of YAP transcription co-activator","volume":"47","author":"Zhu","year":"2015","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.jtos.2024.11.006_bib138","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1909210","article-title":"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.jtos.2024.11.006_bib139","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1016\/j.cub.2012.12.021","article-title":"Intestinal regeneration: YAP-tumor suppressor and oncoprotein?","volume":"23","author":"Li","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.jtos.2024.11.006_bib140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/carcin\/bgq254","article-title":"YAP is a candidate oncogene for esophageal squamous cell carcinoma","volume":"32","author":"Muramatsu","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtos.2024.11.006_bib141","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cas.14725","article-title":"The role of Hippo-YAP signaling in squamous cell carcinomas","volume":"112","author":"Maehama","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib142","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.19.03357","article-title":"Phase II study of pembrolizumab as first-line, single-drug therapy for patients with unresectable cutaneous squamous cell carcinomas","volume":"38","author":"Maubec","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib143","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib144","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(17)30421-7","article-title":"Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial","volume":"18","author":"Harrington","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib145","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib146","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S125059","article-title":"New developments in the management of head and neck cancer - impact of pembrolizumab","volume":"14","author":"Saleh","year":"2018","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.jtos.2024.11.006_bib147","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaophthalmol.2017.2279","article-title":"Pembrolizumab for recurrent conjunctival melanoma","volume":"135","author":"Kini","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2024.11.006_bib148","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/imt-2017-0066","article-title":"PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma","volume":"9","author":"Javed","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jtos.2024.11.006_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263895","article-title":"FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment","volume":"17","author":"Tagami","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0110928","article-title":"Comparative immune phenotypic analysis of cutaneous squamous cell carcinoma and intraepidermal carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ regulatory T-cells is associated with disease stage","volume":"9","author":"Freeman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib152","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib153","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20060195","article-title":"Calcium-dependent and -independent interactions of the S100 protein family","volume":"396","author":"Santamaria-Kisiel","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.jtos.2024.11.006_bib154","first-page":"127","article-title":"Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization","volume":"11","author":"Lunde","year":"2014","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jtos.2024.11.006_bib155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2478\/s11658-009-0011-7","article-title":"The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC)","volume":"14","author":"Strazisar","year":"2009","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jtos.2024.11.006_bib156","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/0008-5472.CAN-08-4231","article-title":"Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma","volume":"69","author":"Chen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib157","article-title":"The role of TG2 in regulating S100A4-mediated mammary tumour cell migration","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-62703-230-8_18","article-title":"In vivo screening of S100B inhibitors for melanoma therapy","volume":"963","author":"Zimmer","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtos.2024.11.006_bib159","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030529","article-title":"S100 as serum tumor marker in advanced uveal melanoma","volume":"13","author":"Salzmann","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtos.2024.11.006_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ctm2.155","article-title":"MUC4 , MUC16 , and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan\u2010cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-019-0107-6","article-title":"Spontaneous mutations in the single TTN gene represent high tumor mutation burden","volume":"5","author":"Oh","year":"2020","journal-title":"Npj Genomic Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib163","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.bbrc.2018.08.077","article-title":"Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573\/E2F3","volume":"503","author":"Chen","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtos.2024.11.006_bib164","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1078-0432.CCR-17-1851","article-title":"Functional role of a novel long noncoding RNA TTN-AS1 in esophageal squamous cell carcinoma progression and metastasis","volume":"24","author":"Lin","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib165","first-page":"1255","article-title":"Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p","volume":"19","author":"Xue","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtos.2024.11.006_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01378-6","article-title":"LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p\/NFAT5 axis","volume":"20","author":"Fu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jtos.2024.11.006_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.127901","article-title":"Titin mutation associated with responsiveness to checkpoint blockades in solid tumors","volume":"4","author":"Jia","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtos.2024.11.006_bib168","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.21037\/tcr-20-2568","article-title":"TTN\/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients","volume":"10","author":"Xue","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib169","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djj068","article-title":"A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype","volume":"98","author":"Naumov","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtos.2024.11.006_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00252","article-title":"Original insights on thrombospondin-1-related antireceptor strategies in cancer","volume":"6","author":"Jeanne","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtos.2024.11.006_bib171","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jop.12430","article-title":"THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma","volume":"45","author":"Pal","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib172","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1073\/pnas.1004934107","article-title":"B-RafV600Eand thrombospondin-1 promote thyroid cancer progression","volume":"107","author":"Nucera","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib173","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1158\/1078-0432.CCR-08-3027","article-title":"Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen","volume":"15","author":"Papadaki","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib174","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1167\/iovs.05-1305","article-title":"Unique distribution of thrombospondin-1 in human ocular surface epithelium","volume":"47","author":"Sekiyama","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.13094","article-title":"MicroRNA-3907 promotes the proliferation and migration of sebaceous gland carcinoma of the eyelid by targeting thrombospondin 1","volume":"22","author":"Zhang","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtos.2024.11.006_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179521","article-title":"Advances of epigenetic biomarkers and epigenome editing for early diagnosis in breast cancer","volume":"23","author":"Sarvari","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib177","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/nbt1010-1045","article-title":"The NIH roadmap epigenomics mapping consortium","volume":"28","author":"Bernstein","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtos.2024.11.006_bib178","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1073\/pnas.052410099","article-title":"Comprehensive analysis of CpG islands in human chromosomes 21 and 22","volume":"99","author":"Takai","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib179","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/j.1742-4658.2006.05343.x","article-title":"The epigenetic magic of histone lysine methylation: delivered on 6 July 2005 at the 30th FEBS Congress in Budapest, Hungary","volume":"273","author":"Jenuwein","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.jtos.2024.11.006_bib180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Saito","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib181","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5858\/2009-0417-OA.1","article-title":"Hypomethylation of the DNMT3L promoter in ocular surface squamous neoplasia","volume":"134","author":"Manderwad","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20133153","article-title":"The role of SIRT1 on DNA damage response and epigenetic alterations in cancer","volume":"20","author":"Alves-Fernandes","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094877","article-title":"miR-196b-5p and miR-107 expression differentiates ocular sebaceous carcinoma from squamous cell carcinoma of the conjunctiva","volume":"23","author":"de Keizer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.11.006_bib184","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib185","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2013.11.020","article-title":"Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation","volume":"155","author":"Hu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib186","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12253-012-9498-8","article-title":"Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA","volume":"18","author":"Livide","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib187","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.exer.2007.10.010","article-title":"Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma","volume":"86","author":"Cohen","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib188","doi-asserted-by":"crossref","first-page":"13341","DOI":"10.1074\/jbc.M413412200","article-title":"Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L","volume":"280","author":"Gowher","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2024.11.006_bib189","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","article-title":"Methylation-induced repression-belts, braces, and chromatin","volume":"99","author":"Bird","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/epi.2.2.3692","article-title":"DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer","volume":"2","author":"Gokul","year":"2007","journal-title":"Epigenetics"},{"key":"10.1016\/j.jtos.2024.11.006_bib191","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.31557\/APJCP.2020.21.12.3605","article-title":"Decoding the genetic alterations in genes of DNMT family (DNA methyl-transferase) and their association with head and neck squamous cell carcinoma","volume":"21","author":"Fathima","year":"2020","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.jtos.2024.11.006_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0093561","article-title":"The CpG Island encompassing the promoter and first exon of human DNMT3LGene is a PcG\/TrXresponse element (PRE)","volume":"9","author":"Basu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib193","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","article-title":"14-3-3sigma is a p53-regulated inhibitor of G2\/M progression","volume":"1","author":"Hermeking","year":"1997","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib194","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","article-title":"High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer","volume":"97","author":"Ferguson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib195","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1038\/sj.onc.1203898","article-title":"Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma","volume":"19","author":"Iwata","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jtos.2024.11.006_bib196","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.onc.1205256","article-title":"Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia","volume":"21","author":"Gasco","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jtos.2024.11.006_bib197","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jcb.22051","article-title":"Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma","volume":"106","author":"Yi","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jtos.2024.11.006_bib198","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2407-10-217","article-title":"Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis","volume":"10","author":"Zurita","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtos.2024.11.006_bib199","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231220511","article-title":"The role of aberrant DNA methylation in cancer initiation and clinical impacts","volume":"16","author":"Geissler","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-009-0628-2","article-title":"Gene promoter methylation is associated with increased mortality among women with breast cancer","volume":"121","author":"Xu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtos.2024.11.006_bib201","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/cam4.1045","article-title":"A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas","volume":"6","author":"Wang","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtos.2024.11.006_bib202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/mutage\/geu071","article-title":"Chemopreventive mechanism of polypeptides from Chlamy Farreri (PCF) against UVB-induced malignant transformation of HaCaT cells","volume":"30","author":"Han","year":"2015","journal-title":"Mutagenesis"},{"key":"10.1016\/j.jtos.2024.11.006_bib203","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s12253-018-0542-1","article-title":"Promoter DNA methylation and mRNA expression level of p16 gene in oral squamous cell carcinoma: correlation with clinicopathological characteristics","volume":"25","author":"Allameh","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jtos.2024.11.006_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0066587","article-title":"The prognostic value of p16 hypermethylation in cancer: a meta-analysis","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtos.2024.11.006_bib206","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/biot.200700087","article-title":"Function of the SIRTI protein deacetylase in cancer","volume":"2","author":"St\u00fcnkel","year":"2007","journal-title":"Biotechnol J"},{"key":"10.1016\/j.jtos.2024.11.006_bib207","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcp.2014.08.034","article-title":"P53 and Sirt1: routes of metabolism and genome stability","volume":"92","author":"Gonfloni","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtos.2024.11.006_bib208","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/ICO.0b013e31823f7857","article-title":"Expression of SIRT1 in ocular surface squamous neoplasia","volume":"31","author":"Alves","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2024.11.006_bib209","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/OTT.S82378","article-title":"SIRT1 expression is associated with poor prognosis of lung adenocarcinoma","volume":"8","author":"Li","year":"2015","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.jtos.2024.11.006_bib210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21873\/cdp.10086","article-title":"SIRT1 expression is a promising prognostic biomarker in esophageal squamous cell carcinoma: a systematic review and meta-analysis","volume":"2","author":"Otsuka","year":"2022","journal-title":"Cancer Diagnosis Progn"},{"key":"10.1016\/j.jtos.2024.11.006_bib211","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.oooo.2012.12.013","article-title":"SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients","volume":"115","author":"Noguchi","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jtos.2024.11.006_bib212","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4132\/KoreanJPathol.2013.47.4.332","article-title":"SIRT1 expression is associated with good prognosis in colorectal cancer","volume":"47","author":"Jung","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.jtos.2024.11.006_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jtos.2024.11.006_bib214","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jtos.2024.11.006_bib215","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1073\/pnas.0803055105","article-title":"A microRNA DNA methylation signature for human","volume":"105","author":"Lujambio","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0221779","article-title":"Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma","volume":"15","author":"Fadhil","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.11.006_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2021.105108","article-title":"The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review","volume":"125","author":"Al Rawi","year":"2021","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jtos.2024.11.006_bib218","doi-asserted-by":"crossref","first-page":"21098","DOI":"10.1073\/pnas.1015541107","article-title":"MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2024.11.006_bib219","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/wrna.1229","article-title":"MicroRNAs as therapeutic targets in human cancers","volume":"5","author":"Shah","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.jtos.2024.11.006_bib220","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.omtn.2019.01.007","article-title":"Bioengineered let-7c inhibits orthotopic hepatocellular carcinoma and improves overall survival with minimal immunogenicity","volume":"14","author":"Jilek","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jtos.2024.11.006_bib221","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2019.09.013","article-title":"Role of miRNA sponges in hepatocellular carcinoma","volume":"500","author":"Li","year":"2020","journal-title":"Clin Chim Acta"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T09:00:27Z","timestamp":1736758827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":221,"alternative-id":["S1542012424001204"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.11.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular surface squamous neoplasia: Update on genetics, epigenetics and opportunities for targeted therapy","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}